首页> 外国专利> SYNTHESIS AND EVALUATION OF NOVEL PHTHALIMIDE MIMICS AS ANTI-ANGIOGENIC AGENTS

SYNTHESIS AND EVALUATION OF NOVEL PHTHALIMIDE MIMICS AS ANTI-ANGIOGENIC AGENTS

机译:新型邻苯二甲酰亚胺类抗血管生成剂的合成与评价

摘要

The present invention is directed to novel thalidomide derivative compounds that have activity as anti-angiogenic compounds. More particularly the compounds have the general structure: where R1 is selected from the group consisting of H, halo, alkyl, haloalkyl, NH2, hydroxy and alkoxy; R2 is selected from the group consisting of optionally substituted bicyclic, optionally substituted aryl, and R6 is H, or C1-C8 alkyl; R19 is optionally substituted aryl; and m is 0-6.
机译:本发明涉及具有抗血管生成化合物活性的新型沙利度胺衍生物化合物。更特别地,这些化合物具有以下通用结构:其中R 1选自H,卤素,烷基,卤代烷基,NH 2,羟基和烷氧基; R2选自由任选取代的双环,任选取代的芳基组成的组,并且R6为H或C1-C8烷基; R 19是任选取代的芳基; m为0-6。

著录项

  • 公开/公告号EP1389103A2

    专利类型

  • 公开/公告日2004-02-18

    原文格式PDF

  • 申请/专利权人 THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION;

    申请/专利号EP20020726787

  • 发明设计人 BROWN MILTON L.;

    申请日2002-04-22

  • 分类号A61K31/40;A61K31/47;A61K31/517;A61K31/55;A61K31/44;A61K31/33;A61P35/00;C07D209/48;C07D217/22;C07D239/72;C07D401/00;C07D451/00;

  • 国家 EP

  • 入库时间 2022-08-21 22:53:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号